source
- Novartis pays $575 million upfront for worldwide rights to Abogen’s CD19xCD3 mRNA T-cell engagerNovartis announced it will pay Abogen Biosciences $575 million upfront for exclusive worldwide rights to its lead early‑stage CD19xCD3 mRNA T‑cell engager. The agreement gives Novartis access to t…
- Bayer outlines $2.2 billion Ohio plant that will add roughly 600 jobsBayer announced its plan for a new manufacturing complex in New Albany, Ohio, with an investment of about $2.2 billion. The facility is expected to create roughly 600 new jobs in the region, suppo…